Seroepidemiological survey of the human immunodeficiency Virus, type 2.
DOI:
https://doi.org/10.20344/amp.1098Abstract
To perform a seroepidemiological study and identify associated factors in a population infected by Human Immunodeficiency Virus, type 2 (HIV-2). A total of 2202 individuals were tested to determine the seroprevalence of this virus.A nine-years retrospective study was performed in 211 HIV-2 seropositives screened by ELISA and confirmed by Western Blot analysis. Eighty-two individuals were analised by synthetic peptides and 15 had an antibody pattern of double reactivity to HIV-1 and HIV-2.The mean age of the HIV-2 - infected individuals was 37.44+/-14.83 years (men 38,34+/-17,18 years; women 36,77+/-12,89 years). There were 23.7% infection cases (95% CI, 18.1-30.0) in the age group 40-49 years. The infection was higher in females 57.8% (95% CI, 50.8-64.6) than in males 42.2% (95% CI, 35.4-49.2). HIV-2 infection in Blacks was 61.6 % (95% CI, 54.7-68.2). In respects to their geographical origin, the Portuguese represented 51.7% (95% CI, 44.7-58.6) followed by Guinean (Bissau) with 26.5% (95% CI, 20.7-33.0). The main mode of transmission of HIV-2 infection appears to be heterosexual transmission with 59.3% (95% CI, 47.8-70.1). Most of the evaluated individuals 54.3% (95% CI, 46.6-61.9) were classified as CDC stage II. HIV-2 seroprevalence was 1%.In considering the comparative data on the two periods of 4.5 years each, an increase of the infection in Caucasians from 32.4% to 43.4% was seen as well as a reduction in Blacks from 67.6% to 55.7%. An increase in asymptomatic persons and a reduction in the CDC stage IV/C1 was also observed. This study emphasis the need to continue efforts to decrease transmission of HIV-2 that should be directed toward epidemic and endemic regions and education about the risks of sexual transmission and how to decrease transmission by this route.Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.